Pfizer Inc (PFE) stock
PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 28, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3048% above fair value
$28.06−0.41 (-1.44%)
Close on Nov 18, 2026Market cap $159.93BP/E 36.9Yield 6.13%
Pfizer price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Pfizer's price to sales ratio was 2.6× on Nov 10, 2026, against 2.3× a year earlier. Over the last 5 years it ranged from 2.1× to 4.9×, with a median of 2.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 10, 2026 | 2.6× | +0.4 |
| 2025 | Dec 31, 2025 | 2.3× | −0.2 |
| 2024 | Dec 31, 2024 | 2.5× | +0.2 |
| 2023 | Dec 29, 2023 | 2.3× | −0.6 |
| 2022 | Dec 30, 2022 | 2.9× | −1.9 |
| 2021 | Dec 31, 2021 | 4.9× | −1.6 |
| 2020 | Dec 31, 2020 | 6.5× | +0.9 |
| 2019 | Dec 31, 2019 | 5.6× | +0.7 |
| 2018 | Dec 31, 2018 | 4.9× | +0.7 |
| 2017 | Dec 29, 2017 | 4.2× | +0.4 |
| 2016 | Dec 30, 2016 | 3.8× | −0.5 |
| 2015 | Dec 31, 2015 | 4.2× | +0.2 |
| 2014 | Dec 31, 2014 | 4.0× | −0.2 |
| 2013 | Dec 31, 2013 | 4.2× | +0.7 |
| 2012 | Dec 31, 2012 | 3.5× | +0.9 |
| 2011 | Dec 30, 2011 | 2.6× | +0.5 |
| 2010 | Dec 31, 2010 | 2.1× | −0.5 |
| 2009 | Dec 31, 2009 | 2.7× | – |
See a number that looks wrong?